Basics Vera Therapeutics, Inc. IPO Date: May 14, 2021 Sector: Healthcare Industry: Biotech Market Cap: $2.87B Activated in VL: True Average Daily Range Avg Daily Range: $0.77 | 3.41% Avg Daily Range (30 D): $1.32 | 4.40% Avg Daily Range (90 D): $0.82 | 3.00% Institutional Daily Volume Avg Daily Volume: .54M Avg Daily Volume (30 D): 1.53M Avg Daily Volume (90 D): 1.45M Trade Size Avg Trade Size (Sh.): 72 Avg Trade Size (Sh.) (30 D): 65 Avg Trade Size (Sh.) (90 D): 76 Institutional Trades Total Inst.Trades: 1,852 Avg Inst. Trade: $2.25M Avg Inst. Trade (30 D): $2.33M Avg Inst. Trade (90 D): $2.25M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.39M Avg Closing Trade (30 D): $4.45M Avg Closing Trade (90 D): $3.43M Avg Closing Volume: 117.72K     News Nov 21, 2025 @ 3:50 PM BK Virus Infection Market Trends, Strategies and B... Source: Researchandmarkets.Com Nov 7, 2025 @ 11:27 PM Vera Therapeutics Submits Biologics License Applic... Source: Vera Therapeutics Aug 6, 2025 @ 6:05 AM Vera (VERA) Q2 Net Loss Widens 127% Source: Jesterai Jul 10, 2025 @ 11:05 PM Vera Therapeutics Reports Inducement Grants Under ... Source: Vera Therapeutics, Inc. Jun 12, 2025 @ 8:22 PM Analysts Can't Get Enough of These Little-Known Bi... Source: Marketbeat.Com Financials   TTM Q3 2025 Q2 2025 Basic EPS $-3.99 $-1.26 $-1.2 Diluted EPS $-3.99 $-1.26 $-1.2 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -251.94M $ -80.29M $ -76.53M Operating Income / Loss $ -270.18M $ -83.93M $ -80.14M Cost of Revenue $ $ $ Net Cash Flow $ 30.52M $ 8.65M $ -5.97M PE Ratio